NCT07387926
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- Novartis Investigative Site Ramat Gan, Israel
Clinical trial condition
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Explore clinical trials studying Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.
7 public trials
3 recruiting studies
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia trial results
Recruiting
Asciminib Maintenance Therapy Following alloHCT or CAR T to Prevent Relapse in Adults With Ph+ALL
NCT07250087
- Conditions
- Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
NCT06061094
- Conditions
- Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Locations
-
- Uniklinik RWTH Aachen Aachen, Germany
- Klinikum Aschaffenburg Aschaffenburg, Germany
- Klinikum Augsburg Augsburg, Germany
- Helios Klinikum Bad Saarow Bad Saarow, Germany
Enrolling by Invitation
Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia
NCT06773936
- Conditions
- CD19+ Acute Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- UC Irvine Medical Center Orange, California, United States
- Northwell Health/Center for Advanced Medicine Lake Success, New York, United States
- University of Rochester Medical Center Rochester, New York, United States
- Duke University Medical Center Durham, North Carolina, United States
Not Yet Recruiting
Evaluation of the Efficacy of Ponatinib in Ph+ ALL in the Real-world
NCT07356960
- Conditions
- Acute Lymphobkastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
Not specified
Completed
Olverembatinib Combined With Reduced-Intensity Chemotherapy and Venetoclax for de Novo Ph+ ALL
NCT05594784
- Conditions
- Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, China
NCT01030718
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +12 more
- Locations
-
Not specified